中核鈦白(002145.SZ):擬受讓子公司所持和誠鈦業、東方鈦業100%股權
格隆匯 12 月 9日丨中核鈦白(002145.SZ)公佈,公司將全資子公司安徽金星鈦白(集團)有限公司(“金星鈦白”)持有的甘肅和誠鈦業有限公司(“和誠鈦業”)、甘肅東方鈦業有限公司(“東方鈦業”)100%股權劃轉給公司。此次股權劃轉完成後,公司將直接持有和誠鈦業、東方鈦業100%股權,和誠鈦業、東方鈦業將由公司全資孫公司變更為全資子公司。
此次股權劃轉有利於公司整合內部資源、優化業務架構,更好地提高管理效率和運營效率,降低公司運營成本,符合公司的整體戰略規劃;也有利於公司進一步完善治理結構,對公司的長遠發展和業務佈局具有積極作用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.